Medical Research and Thermo Fisher

Selected news for the healthcare topic - Medical Research, and the company - Thermo Fisher. We have 4,824 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/11/2022 Oakworth Capital Inc. Buys 70 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - Watch List News Oakworth Capital Inc. lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.0% during the third quarter, HoldingsChannel reports. The firm owned 2,375 shares of the medical research company‚Aos stock after buying an additional 70 shares during the quarter. Oakworth Capital Inc.‚Aos holdings in Thermo Fisher Scientific were worth $1,357,000 at the end of the most recent quarter.Several other hedge funds and other ...
12/30/2021 Abbrea Capital LLC Buys 554 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) Abbrea Capital LLC raised its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 49.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,665 shares of the medical research company‚Aos stock after acquiring an additional 554 shares during the quarter. Abbrea Capital LLC‚Aos holdings in Thermo Fisher Scientific were worth $952,000 at the end ...
12/30/2021 Abbrea Capital LLC Buys 554 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) Abbrea Capital LLC raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 49.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,665 shares of the medical research company‚Aos stock after buying an additional 554 shares during the quarter. Abbrea Capital LLC‚Aos holdings in Thermo Fisher Scientific were worth $952,000 as ...
12/30/2021 Xponance Inc. Sells 1,981 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - Transcript Daily Xponance Inc. decreased its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 31,446 shares of the medical research company‚Aos stock after selling 1,981 shares during the quarter. Xponance Inc.‚Aos holdings in Thermo Fisher Scientific were worth $17,966,000 at the end of the most recent reporting period.Several ...
12/30/2021 Cullen Frost Bankers Inc. Acquires 9,988 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - WKRB News Cullen Frost Bankers Inc. raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 107.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 19,294 shares of the medical research company‚Aos stock after purchasing an additional 9,988 shares during the period. Cullen Frost Bankers Inc.‚Aos holdings in Thermo Fisher Scientific were worth $11,024,000 as of ...
12/29/2021 Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Kornitzer Capital Management Inc. KS - Watch List News Kornitzer Capital Management Inc. KS lessened its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 11.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,761 shares of the medical research company‚Aos stock after selling 1,100 shares during the quarter. Kornitzer Capital Management Inc. KS‚Aos holdings in Thermo Fisher Scientific ...
12/29/2021 Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Kornitzer Capital Management Inc. KS - American Banking News American Banking News Kornitzer Capital Management Inc. KS lessened its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 11.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,761 shares of the medical research company‚Aos stock after selling 1,100 shares during the quarter. Kornitzer Capital Management Inc. KS‚Aos holdings in Thermo Fisher Scientific ...
10/4/2021 Thermo Fisher Scientific Inc. (NYSE:TMO) Expected to Announce Quarterly Sales of $8.27 Billion Brokerages expect Thermo Fisher Scientific Inc. (NYSE:TMO) to post sales of $8.27 billion for the current fiscal quarter, according to Zacks Investment Research . Five analysts have issued estimates for Thermo Fisher Scientific‚Aos earnings ... announced its quarterly earnings data on Wednesday, July 28th. The medical research company reported $5.60 EPS for the quarter, topping the Zacks‚Ao consensus estimate of $5.51 by $0.09. The firm had revenue of $9.27 ...
10/4/2021 Henrietta Lacks estate sues company using her 'stolen' cells ... medical research without her permission, outside the federal courthouse in Baltimore, Monday, Oct. 4, 2021. They announced during a news conference that Lacks' estate is filing a lawsuit against Thermo Fisher Scientific for using Lacks' cells, known as HeLa cells. Steve Ruark/AP Show More Show Less 2 of 6 Attorney Ben Crump, second from left, walks with Ron Lacks, left, Alfred Lacks Carter, third from left, both grandsons of ...
9/29/2021 Thermo Fisher Scientific Inc. (NYSE:TMO) Holdings Lowered by Knights of Columbus Asset Advisors LLC The Markets Daily Knights of Columbus Asset Advisors LLC trimmed its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,209 shares of the medical research company‚Aos stock after selling 32 shares during the quarter. Knights of Columbus Asset Advisors LLC‚Aos holdings in Thermo Fisher Scientific were worth ...
9/29/2021 Barings LLC Cuts Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) Dakota Financial News Barings LLC cut its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 37.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,634 shares of the medical research company‚Aos stock after selling 1,599 shares during the quarter. Barings LLC‚Aos holdings in Thermo Fisher Scientific were worth $1,328,000 at the end of ...
9/28/2021 Jennison Associates LLC Boosts Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) American Banking News Jennison Associates LLC lifted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 742.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 144,897 shares of the medical research company‚Aos stock after buying an additional 127,702 shares during the period. Jennison Associates LLC‚Aos holdings in Thermo Fisher Scientific were worth $73,096,000 at the end of ...
9/27/2021 Boston Family Office LLC Has $18.84 Million Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - WKRB News Boston Family Office LLC increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.3% during the second quarter, Holdings Channel reports. The fund owned 37,353 shares of the medical research company‚Aos stock after acquiring an additional 106 shares during the quarter. Thermo Fisher Scientific makes up 1.3% of Boston Family Office LLC‚Aos holdings, making the stock its 20th largest holding. Boston Family Office LLC ...
9/26/2021 Metabolomics Market Growing at a CAGR of 13.4% - Biomarker Development and Leading Key Players Metabolomics Market Growing at a CAGR of 13.4% - Biomarker Development and Leading Key Players In 2020, Agilent and Thermo Fisher extended their agreement to enhance the compatibility of Thermo Fisher‚Aos analytical systems with Agilent ... the last decade has increased the application of metabolomics in biomedical research. As a result of these technological developments, new biomarkers are being regularly discovered. These biomarkers are required in medical sciences to better define ...
9/25/2021 UBS Group Increases Thermo Fisher Scientific (NYSE:TMO) Price Target to $670.00 Thermo Fisher Scientific (NYSE:TMO) had its price target lifted by UBS Group from $595.00 to $670.00 in a report published on Tuesday, The Fly reports. UBS Group currently has a buy rating on the medical research company‚Aos stock. A number of other research firms also recently weighed in on TMO. The Goldman Sachs Group decreased their target price on Thermo Fisher Scientific from $590.00 to $530.00 and set ...
9/25/2021 UBS Group Increases Thermo Fisher Scientific (NYSE:TMO) Price Target to $670.00 Thermo Fisher Scientific (NYSE:TMO) had its price objective lifted by UBS Group from $595.00 to $670.00 in a report released on Tuesday morning, The Fly reports. They currently have a buy rating on the medical research company‚Aos stock. Other analysts have also issued research reports about the stock. Benchmark initiated coverage on shares of Thermo Fisher Scientific in a research report on Friday, July 16th. They issued a ...
9/25/2021 Thermo Fisher Scientific (NYSE:TMO) PT Raised to $655.00 at Cowen Thermo Fisher Scientific (NYSE:TMO) had its target price boosted by Cowen from $560.00 to $655.00 in a research note issued on Thursday, The Fly reports. The brokerage presently has an ‚Auoutperform‚Au rating on the medical research company‚Aos stock. Cowen‚Aos price objective indicates a potential upside of 7.42% from the company‚Aos current price. Other equities research analysts have also issued reports about the company. Argus raised ...
9/25/2021 Thermo Fisher Scientific (NYSE:TMO) PT Raised to $655.00 - Stock Observer Thermo Fisher Scientific (NYSE:TMO) had its price target boosted by equities researchers at Cowen from $560.00 to $655.00 in a research note issued to investors on Thursday, The Fly reports. The firm presently has an ‚Auoutperform‚Au rating on the medical research company‚Aos stock. Cowen‚Aos target price suggests a potential upside of 7.42% from the stock‚Aos current price.Other analysts have also issued research reports about ...
9/25/2021 Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Palisade Capital Management LLC NJ Palisade Capital Management LLC NJ raised its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 36.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,150 shares of the medical research company‚Aos stock after buying an additional 2,455 shares during the quarter. Palisade Capital Management LLC NJ‚Aos holdings in Thermo Fisher Scientific ...
9/24/2021 Thermo Fisher Scientific (NYSE:TMO) Given New $620.00 Price Target at Citigroup Thermo Fisher Scientific (NYSE:TMO) had its price target hoisted by Citigroup from $535.00 to $620.00 in a research report sent to investors on Monday, The Fly reports. The firm currently has a neutral rating on the medical research company‚Aos stock. Several other research firms have also issued reports on TMO. KeyCorp increased their target price on shares of Thermo Fisher Scientific from $520.00 to $555.00 and gave the ...
9/22/2021 JPMorgan Chase & Co. Boosts Thermo Fisher Scientific (NYSE:TMO) Price Target to $700.00 Thermo Fisher Scientific (NYSE:TMO) had its target price boosted by stock analysts at JPMorgan Chase & Co. from $600.00 to $700.00 in a report released on Monday, The Fly reports. The firm currently has an ‚Auoverweight‚Au rating on the medical research company‚Aos stock. JPMorgan Chase & Co. ‚Aos price target indicates a potential upside of 17.25% from the company‚Aos previous close. A number of other equities analysts have ...
9/22/2021 Thermo Fisher Scientific (NYSE:TMO) PT Raised to $675.00 Thermo Fisher Scientific (NYSE:TMO) had its price objective hoisted by stock analysts at SVB Leerink from $600.00 to $675.00 in a research note issued to investors on Monday, The Fly reports. The brokerage currently has an ‚Auoutperform‚Au rating on the medical research company‚Aos stock. SVB Leerink‚Aos target price would indicate a potential upside of 13.06% from the stock‚Aos current price. SVB Leerink also issued estimates ...
9/22/2021 Q3 2021 EPS Estimates for Thermo Fisher Scientific Inc. Increased by SVB Leerink (NYSE:TMO) - Ticker Report Ticker Report Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai Investment analysts at SVB Leerink lifted their Q3 2021 EPS estimates for shares of Thermo Fisher Scientific in a note issued to investors on Monday, September 20th. SVB Leerink analyst P. Souda now anticipates that the medical research company will earn $4.63 per share for the quarter, up from their prior estimate of $4.51. SVB Leerink has a ‚AuOutperform‚Au rating and a ...
9/22/2021 Q3 2021 EPS Estimates for Thermo Fisher Scientific Inc. Increased by SVB Leerink (NYSE:TMO) - Watch List News Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai Equities research analysts at SVB Leerink raised their Q3 2021 earnings per share estimates for Thermo Fisher Scientific in a report issued on Monday, September 20th. SVB Leerink analyst P. Souda now expects that the medical research company will post earnings per share of $4.63 for the quarter, up from their previous estimate of $4.51. SVB Leerink currently has a ‚AuOutperform‚Au rating ...
9/22/2021 Thermo Fisher Scientific Inc. to Post FY2022 Earnings of $21.35 Per Share, KeyCorp Forecasts (NYSE:TMO) - The Cerbat Gem Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai Equities research analysts at KeyCorp increased their FY2022 EPS estimates for Thermo Fisher Scientific in a research report issued on Sunday, September 19th. KeyCorp analyst P. Knight now expects that the medical research company will earn $21.35 per share for the year, up from their prior estimate of $20.55. KeyCorp currently has a ‚AuOverweight‚Au rating and a $710.00 target price on the ...